Ovation Diagnostics, a Boca Raton-based company committed to improving outcomes of women with ovarian cancer, finalized a funding agreement with The Florida Institute for the Commercialization of Public Research.
The amount of the deal was not disclosed.
Led by Joseph E. Zack, President, Ovation Diagnostics focuses on the development, manufacturing and commercialization of a novel ovarian cancer diagnostic test, to be used in the screening, prognosis, therapy selection, and monitoring of ovarian cancer.
The company was founded in 2014, and the licensing agreement was secured from University of South Florida in 2015.
FinSMEs
19/08/2016